{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T01:23:09Z","timestamp":1778030589213,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Institute of Molecular Biology and Biochemistry"},{"name":"Franz-Lanyar-Stiftung","award":["#372"],"award-info":[{"award-number":["#372"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.mcn.2016.03.004","type":"journal-article","created":{"date-parts":[[2016,3,21]],"date-time":"2016-03-21T23:50:45Z","timestamp":1458604245000},"page":"34-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Brain cortical cholesterol metabolism is highly affected by human APP overexpression in mice"],"prefix":"10.1016","volume":"74","author":[{"given":"Tina","family":"L\u00f6ffler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Schweinzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Flunkert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5176-6143","authenticated-orcid":false,"given":"Mikl\u00f3s","family":"S\u00e1ntha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Windisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst","family":"Steyrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Hutter-Paier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2016.03.004_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"Heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","author":"MRC\/BHF","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mcn.2016.03.004_bb0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.neuint.2006.01.026","article-title":"Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis","volume":"49","author":"Bjelik","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.mcn.2016.03.004_bb0015","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1073\/pnas.0913828107","article-title":"ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD","volume":"107","author":"Bryleva","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2016.03.004_bb0020","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.mcn.2016.03.004_bb0025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1212\/01.wnl.0000319647.15752.7b","article-title":"Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study","volume":"71","author":"Cramer","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2016.03.004_bb0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neuroscience.2011.09.009","article-title":"Positive correlation between elevated plasma cholesterol levels and cognitive impairments in LDL receptor knockout mice: relevance of cortico-cerebral mitochondrial dysfunction and oxidative stress","volume":"197","author":"de Oliveira","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.mcn.2016.03.004_bb0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrn3012","article-title":"Linking lipids to Alzheimer's disease: cholesterol and beyond","volume":"12","author":"Di Paolo","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.mcn.2016.03.004_bb0040","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000017234","article-title":"Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease","volume":"11","author":"Eckert","year":"2000","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.mcn.2016.03.004_bb0045","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1083\/jcb.200207113","article-title":"Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts","volume":"160","author":"Ehehalt","year":"2003","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.mcn.2016.03.004_bb0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jns.2012.07.002","article-title":"Chronic vascular risk factors (cholesterol, homocysteine, ethanol) impair spatial memory, decline cholinergic neurons and induce blood\u2013brain barrier leakage in rats in vivo","volume":"322","author":"Ehrlich","year":"2012","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.mcn.2016.03.004_bb0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrneurol.2009.215","article-title":"The clinical use of structural MRI in Alzheimer disease","volume":"6","author":"Frisoni","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.mcn.2016.03.004_bb0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jnutbio.2006.07.003","article-title":"Beta-amyloid or its precursor protein is found in epithelial cells of the small intestine and is stimulated by high-fat feeding","volume":"18","author":"Galloway","year":"2007","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.mcn.2016.03.004_bb0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.molmed.2007.06.004","article-title":"Amyloid beta as a regulator of lipid homeostasis","volume":"13","author":"Grimm","year":"2007","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.mcn.2016.03.004_bb0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00221-011-2975-6","article-title":"The role of APP proteolytic processing in lipid metabolism","volume":"217","author":"Grimm","year":"2012","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.mcn.2016.03.004_bb0075","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ncb1313","article-title":"Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin","volume":"7","author":"Grimm","year":"2005","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.mcn.2016.03.004_bb0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","article-title":"The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics","volume":"297","author":"Hardy","year":"2002","journal-title":"Science"},{"issue":"Suppl. 1","key":"10.1016\/j.mcn.2016.03.004_bb0085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1471-4159.2007.04715.x","article-title":"Alzheimer's disease: the lipid connection","volume":"103","author":"Hartmann","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2016.03.004_bb0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/JAD-2011-101866","article-title":"A longitudinal study of behavioral deficits in an AbetaPP transgenic mouse model of Alzheimer's disease","volume":"25","author":"Havas","year":"2011","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.mcn.2016.03.004_bb0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1194\/jlr.M300320-JLR200","article-title":"Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease","volume":"45","author":"Heverin","year":"2004","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mcn.2016.03.004_bb0100","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.exger.2010.11.032","article-title":"Chronic mild cerebrovascular dysfunction as a cause for Alzheimer's disease?","volume":"46","author":"Humpel","year":"2011","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.mcn.2016.03.004_bb0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuron.2004.08.043","article-title":"The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease","volume":"44","author":"Hutter-Paier","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2016.03.004_bb0110","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1096\/fj.09-134999","article-title":"Inhibition of acyl-coenzyme A: cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathway","volume":"23","author":"Huttunen","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.mcn.2016.03.004_bb0115","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/NEN.0b013e3181e77ed9","article-title":"The acyl-coenzyme A: cholesterol acyltransferase inhibitor CI-1011 reverses diffuse brain amyloid pathology in aged amyloid precursor protein transgenic mice","volume":"69","author":"Huttunen","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.mcn.2016.03.004_bb0120","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI11013","article-title":"Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway","volume":"106","author":"Kang","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mcn.2016.03.004_bb0125","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1136\/bmj.322.7300.1447","article-title":"Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study","volume":"322","author":"Kivipelto","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.mcn.2016.03.004_bb0130","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1212\/01.wnl.0000277657.95487.1c","article-title":"Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease","volume":"69","author":"Li","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2016.03.004_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2013.04.008","article-title":"Impact of ApoB-100 expression on cognition and brain pathology in wild-type and hAPPsl mice","author":"Loffler","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.mcn.2016.03.004_bb0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1742-2094-11-84","article-title":"Neuroinflammation and related neuropathologies in APPSL mice: further value of this in vivo model of Alzheimer's disease","volume":"11","author":"Loffler","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.mcn.2016.03.004_bb0145","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1096\/fj.10-168633","article-title":"Local cholesterol increase triggers amyloid precursor protein-Bace1 clustering in lipid rafts and rapid endocytosis","volume":"25","author":"Marquer","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.mcn.2016.03.004_bb0150","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/0006-291X(90)90635-Z","article-title":"Detection of soluble forms of the beta-amyloid precursor protein in human plasma","volume":"167","author":"Podlisny","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mcn.2016.03.004_bb0155","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbr.2006.11.044","article-title":"Non-cognitive behaviours in an APP\/PS1 transgenic model of Alzheimer's disease","volume":"178","author":"Pugh","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.mcn.2016.03.004_bb0160","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/ncb1001-905","article-title":"Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide","volume":"3","author":"Puglielli","year":"2001","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.mcn.2016.03.004_bb0165","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1194\/jlr.R300007-JLR200","article-title":"Cholesterol: from heart attacks to Alzheimer's disease","volume":"44","author":"Raffai","year":"2003","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.mcn.2016.03.004_bb0170","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1212\/WNL.0b013e318228bf11","article-title":"A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease","volume":"77","author":"Sano","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2016.03.004_bb0175","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.mcn.2016.03.004_bb0180","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood\u2013brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mcn.2016.03.004_bb0185","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","article-title":"Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons","volume":"95","author":"Simons","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2016.03.004_bb0190","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1159\/000231980","article-title":"Midlife serum cholesterol and increased risk of Alzheimer's and vascular dementia three decades later","volume":"28","author":"Solomon","year":"2009","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.mcn.2016.03.004_bb0195","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.bbalip.2010.03.007","article-title":"Membrane rafts in Alzheimer's disease beta-amyloid production","volume":"1801","author":"Vetrivel","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.mcn.2016.03.004_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0009-9163.2004.00280.x","article-title":"Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism","volume":"66","author":"Wellington","year":"2004","journal-title":"Clin. Genet."},{"key":"10.1016\/j.mcn.2016.03.004_bb0205","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/archneur.57.10.1439","article-title":"Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors","volume":"57","author":"Wolozin","year":"2000","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.mcn.2016.03.004_bb0210","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/jnc.12637","article-title":"Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis","volume":"129","author":"Wood","year":"2014","journal-title":"J. Neurochem."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743116300197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743116300197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T01:00:11Z","timestamp":1572397211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743116300197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":42,"alternative-id":["S1044743116300197"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2016.03.004","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain cortical cholesterol metabolism is highly affected by human APP overexpression in mice","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2016.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}